Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Particulate & foreign matter

Visible foreign particles - glass, metal, fibers or other material - found in the product. Particles can enter from equipment wear, containers or the process, and are dangerous in injectables.

867 FDA drug recalls with this cause, newest first.

These recalls involve visible foreign material - glass, metal, fibers, rubber or other debris - most often found in injectable or liquid products, where nothing besides the intended ingredients should be present. It also includes foreign tablets or capsules found in a bottle of a different product. In an injectable a stray particle can go straight into the bloodstream, which is why a noticeable share of these recalls are Class I.

Total recalls
867
Class I (high risk)
184
Currently ongoing
210
Most recent
Aug 24, 2026

Most-cited firms for this cause

  • Pharmedium Services, LLC89
  • Hospira Inc.46
  • QuVa Pharma, Inc.29
  • Baxter Healthcare Corp.26
  • F.H. INVESTMENTS, Inc. (dba Asteria Health)25
  • Guardian Drug Co. Inc.23
  • Lupin Pharmaceuticals Inc.18
  • Fresenius Kabi USA, LLC18
Class I · High risk

Dextrose Injection

Presence of Particulate Matter: particulate matter identified as stainless steel particles in the solution.

Ongoing Particulate / foreign matter Baxter Healthcare Corporation NDC 00338-0719-06 D-0850-2026
Class I · High risk

Tyenne (tocilizumab-aazg)

Presence of particulate matter:An internal investigation at the firm found the product to contain glass particles.

Ongoing Particulate / foreign matter Fresenius Kabi USA, LLC NDC 65219-594-20 D-0827-2026
Class II · Moderate risk

Acthar Gel

Presence of particulate matter: glass and stopper piece

Ongoing Particulate / foreign matter Mallinckrodt Hospital Products Inc. NDC 63004-8710-1 D-0803-2026
Class II · Moderate risk

SEMAGLUTIDE 20mg

Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material

Ongoing Particulate / foreign matter Apollo Care, LLC NDC 71170-724-04 D-0757-2026
Class II · Moderate risk

SEMAGLUTIDE 10mg

Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material

Ongoing Particulate / foreign matter Apollo Care, LLC NDC 71170-722-02 D-0756-2026
Class II · Moderate risk

SEMAGLUTIDE 7.5mg

Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material

Ongoing Particulate / foreign matter Apollo Care, LLC NDC 71170-721-01 D-0755-2026
Class II · Moderate risk

SEMAGLUTIDE 5mg

Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material

Ongoing Particulate / foreign matter Apollo Care, LLC NDC 71170-712-03 D-0754-2026
Class II · Moderate risk

SEMAGLUTIDE 2.5mg

Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material

Ongoing Particulate / foreign matter Apollo Care, LLC NDC 71170-711-02 D-0753-2026
Class II · Moderate risk

SEMAGLUTIDE 0.9mg

Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material

Ongoing Particulate / foreign matter Apollo Care, LLC NDC 71170-810-01 D-0752-2026
Class II · Moderate risk

SEMAGLUTIDE 9mg

Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material

Ongoing Particulate / foreign matter Apollo Care, LLC NDC 71170-822-02 D-0751-2026
Class II · Moderate risk

SEMAGLUTIDE 4.5mg

Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material

Ongoing Particulate / foreign matter Apollo Care, LLC NDC 71170-812-03 D-0750-2026
Class II · Moderate risk

SEMAGLUTIDE 6.75mg

Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material

Ongoing Particulate / foreign matter Apollo Care, LLC NDC 71170-821-01 D-0749-2026
Class II · Moderate risk

Semaglutide 2.25mg

Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material

Ongoing Particulate / foreign matter Apollo Care, LLC NDC 71170-811-02 D-0748-2026
Class II · Moderate risk

Semaglutide 12.5mg

Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material

Ongoing Particulate / foreign matter Apollo Care, LLC NDC 71170-495-05 D-0747-2026
Class I · High risk

Papaverine HCl Injection

Presence of Particulate Matter: Product contaminated with particulate matter identified as glass and/or paraformaldehyde

Ongoing Particulate / foreign matter American Regent, Inc. NDC 0517-4002-01 D-0800-2026